Literature DB >> 22095986

NADPH oxidase 4 mediates monocyte priming and accelerated chemotaxis induced by metabolic stress.

Sarah Ullevig1, Qingwei Zhao, Chi Fung Lee, Hong Seok Kim, Debora Zamora, Reto Asmis.   

Abstract

OBJECTIVE: Metabolic disorders increase monocyte chemoattractant protein-1 (MCP-1)-induced monocyte chemotaxis in mice. The goal of this study was to determine the molecular mechanisms responsible for the enhanced responsiveness of monocytes to chemoattractants induced by metabolic stress. METHODS AND
RESULTS: Chronic exposure of monocytes to diabetic conditions induced by human LDL plus high D-glucose concentrations (LDL+HG) promoted NADPH Oxidase 4 (Nox4) expression, increased intracellular H(2)O(2) formation, stimulated protein S-glutathionylation, and increased chemotaxis in response to MCP-1, platelet-derived growth factor B, and RANTES. Both H(2)O(2) added exogenously and overexpression of Nox4 mimicked LDL+HG-induced monocyte priming, whereas Nox4 knockdown protected monocytes against metabolic stress-induced priming and accelerated chemotaxis. Exposure of monocytes to LDL+HG promoted the S-glutathionylation of actin, decreased the F-actin/G-actin ratio, and increased actin remodeling in response to MCP-1. Preventing LDL+HG-induced protein S-glutathionylation by overexpressing glutaredoxin 1 prevented monocyte priming and normalized monocyte chemotaxis in response to MCP-1. Induction of hypercholesterolemia and hyperglycemia in C57BL/6 mice promoted Nox4 expression and protein S-glutathionylation in macrophages, and increased macrophage recruitment into MCP-1-loaded Matrigel plugs implanted subcutaneous in these mice.
CONCLUSIONS: By increasing actin-S-glutathionylation and remodeling, metabolic stress primes monocytes for chemoattractant-induced transmigration and recruitment to sites of vascular injury. This Nox4-dependent process provides a novel mechanism through which metabolic disorders promote atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095986      PMCID: PMC3262086          DOI: 10.1161/ATVBAHA.111.238899

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  60 in total

Review 1.  Mechanisms of platelet-derived growth factor-induced chemotaxis.

Authors:  L Rönnstrand; C H Heldin
Journal:  Int J Cancer       Date:  2001-03-15       Impact factor: 7.396

2.  Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3.

Authors:  E S Wintergerst; J Jelk; C Rahner; R Asmis
Journal:  Eur J Biochem       Date:  2000-10

3.  Large variations in human foam cell formation in individuals: a fully autologous in vitro assay based on the quantitative analysis of cellular neutral lipids.

Authors:  R Asmis; J Jelk
Journal:  Atherosclerosis       Date:  2000-02       Impact factor: 5.162

4.  Reversible glutathionylation regulates actin polymerization in A431 cells.

Authors:  J Wang; E S Boja; W Tan; E Tekle; H M Fales; S English; J J Mieyal; P B Chock
Journal:  J Biol Chem       Date:  2001-10-29       Impact factor: 5.157

5.  Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo.

Authors:  K Wingler; S Wünsch; R Kreutz; L Rothermund; M Paul; H H Schmidt
Journal:  Free Radic Biol Med       Date:  2001-12-01       Impact factor: 7.376

6.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.

Authors:  M I Cybulsky; K Iiyama; H Li; S Zhu; M Chen; M Iiyama; V Davis; J C Gutierrez-Ramos; P W Connelly; D S Milstone
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

7.  Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice.

Authors:  K Zibara; E Chignier; C Covacho; R Poston; G Canard; P Hardy; J McGregor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

8.  Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

Authors:  Christophe Combadière; Stéphane Potteaux; Ji-Liang Gao; Bruno Esposito; Saveria Casanova; Eric J Lee; Patrice Debré; Alain Tedgui; Philip M Murphy; Ziad Mallat
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

9.  Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule.

Authors:  I Dalle-Donne; D Giustarini; R Rossi; R Colombo; A Milzani
Journal:  Free Radic Biol Med       Date:  2003-01-01       Impact factor: 7.376

10.  P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice.

Authors:  R G Collins; R Velji; N V Guevara; M J Hicks; L Chan; A L Beaudet
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

View more
  47 in total

1.  Glutathione adducts induced by ischemia and deletion of glutaredoxin-1 stabilize HIF-1α and improve limb revascularization.

Authors:  Yosuke Watanabe; Colin E Murdoch; Soichi Sano; Yasuo Ido; Markus M Bachschmid; Richard A Cohen; Reiko Matsui
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 2.  Mitogen-activated protein kinase phosphatase 1 (MKP-1) in macrophage biology and cardiovascular disease. A redox-regulated master controller of monocyte function and macrophage phenotype.

Authors:  Hong Seok Kim; Reto Asmis
Journal:  Free Radic Biol Med       Date:  2017-03-19       Impact factor: 7.376

3.  NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways.

Authors:  Qingwei David Zhao; Suryavathi Viswanadhapalli; Paul Williams; Qian Shi; Chunyan Tan; Xiaolan Yi; Basant Bhandari; Hanna E Abboud
Journal:  Circulation       Date:  2015-01-14       Impact factor: 29.690

Review 4.  Actin filaments-A target for redox regulation.

Authors:  Carlos Wilson; Jonathan R Terman; Christian González-Billault; Giasuddin Ahmed
Journal:  Cytoskeleton (Hoboken)       Date:  2016-08-06

5.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

6.  Redox regulation of 14-3-3ζ controls monocyte migration.

Authors:  Hong Seok Kim; Sarah L Ullevig; Huynh Nga Nguyen; Difernando Vanegas; Reto Asmis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-08       Impact factor: 8.311

7.  EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC.

Authors:  Elise V M Fletcher; Laurie Love-Homan; Arya Sobhakumari; Charlotte R Feddersen; Adam T Koch; Apollina Goel; Andrean L Simons
Journal:  Mol Cancer Res       Date:  2013-09-18       Impact factor: 5.852

Review 8.  NADPH oxidases in lung health and disease.

Authors:  Karen Bernard; Louise Hecker; Tracy R Luckhardt; Guangjie Cheng; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

Review 9.  The inflammation highway: metabolism accelerates inflammatory traffic in obesity.

Authors:  Amy R Johnson; J Justin Milner; Liza Makowski
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

10.  Signaling lymphocyte activation molecule regulates development of colitis in mice.

Authors:  Boaz van Driel; Gongxian Liao; Xavier Romero; Michael S O'Keeffe; Guoxing Wang; William A Faubion; Scott B Berger; Erica M Magelky; Monika Manocha; Veronica Azcutia; Matthew Grisham; Francis W Luscinskas; Emiko Mizoguchi; Rene de Waal Malefyt; Hans-Christian Reinecker; Atul K Bhan; Ninghai Wang; Cox Terhorst
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.